Xiaodong Wang, Director at BeiGene, Ltd. (BGNE), sold 13,592 shares at $257.41 ($3.5M) on 2025-03-04, disclosed to the SEC on 2025-03-06.
Scheduled sale ($3.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $251.70 | 700 | $176K | 5.1% |
| 2 | $252.72 | 2,000 | $505K | 14.6% |
| 3 | $253.55 | 825 | $209K | 6.0% |
| 4 | $253.55 | 825 | $209K | 6.0% |
| 5 | $254.77 | 1,275 | $325K | 9.4% |
| 6 | $254.77 | 1,275 |
| $325K |
| 9.4% |
| 7 | $255.71 | 1,214 | $310K | 9.0% |
| 8 | $255.71 | 1,214 | $310K | 9.0% |
| 9 | $256.83 | 1,809 | $465K | 13.4% |
| 10 | $256.83 | 1,809 | $465K | 13.4% |
| 11 | $257.41 | 323 | $83K | 2.4% |
| 12 | $257.41 | 323 | $83K | 2.4% |
| Total | $255.00 avg | 13,592 | $3.5M | 100% |
| Filing → |
| ONC | SELL | 2025-06-25 | $668K | — | Filing → |
| ONC | SELL | 2025-06-12 | $21.9M | — | Filing → |
| BGNE | SELL | 2025-05-15 | $18.6M | — | Filing → |